A Randomized open label clinical trial for evaluation of efficacy and safety of Prazosin and Prazosin with scorpion anti- Venom combination in victims of venomous scorpion ( Mesobuthus Tamulus ) sting.
Not Applicable
- Registration Number
- CTRI/2010/091/000584
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Patients were eligible for enrollment if they reported to hospital with MT scorpion bite, with grade II, with an interval less than 6 hours between scorpion bite and hospitalization; age > 6 months. MT scorpion bite was confirmed if patient have seen red scorpion or brought the killed specimen or confirmed by showing him the hospital preserved specimen or photograph
Exclusion Criteria
Major exclusion criteria were, patient reporting after six hours of sting, pregnant women, previous history of taking prazosin or scorpion Antivenom, patient with history of bronchial asthma or previous history of allergic reaction to foreign serum and who refused to give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method